Top Markets
Coin of the day
Caris Life Sciences, Inc. Caris Life Sciences, Inc.

Caris Life Sciences, Inc.

CAI
Rang in Aktien #2605
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing... Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
Aktienkurs
$27.75
Marktkapitalisierung
$7.84B
Veränderung (1 Tag)
6.21%
Veränderung (1 Jahr)
-27.88%
Land
US
Handel Caris Life Sciences, Inc. (CAI)

Kategorie

Aktien-Split-Historie für Caris Life Sciences, Inc. (CAI)
Die Aktie Caris Life Sciences, Inc. (Symbol: CAI) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 25, 2026 statt.
Eine CAI-Aktie, die vor dem Aug 25, 2026 gekauft wurde, entspricht heute 0 CAI-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH